Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2D | O15399 | 5/20 | 0.44 |
| ▸ | GRIN3B | O60391 | 5/20 | 0.44 |
| ▸ | GRIN1 | Q05586 | 5/20 | 0.44 |
| ▸ | GRIN2A | Q12879 | 5/20 | 0.44 |
| ▸ | GRIN2B | Q13224 | 5/20 | 0.44 |
| ▸ | GRIN2C | Q14957 | 5/20 | 0.44 |
| ▸ | GRIN3A | Q8TCU5 | 5/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | SLC22A2 | O15244 | 2/20 | 0.44 |
| ▸ | SLC47A1 | Q96FL8 | 2/20 | 0.44 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | STAT6 | P42226 | 1/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphine SCHEMBL28211022 | 0.96 | GRIN2D (0.42) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| Acetic Acid SCHEMBL28387664 | 0.81 | THRB (0.46) | THRBGAAEPHX2EPHX1 | |
| SCHEMBL18171379 | 0.79 | — | — | |
| SCHEMBL5269244 | 0.79 | THRB (0.48) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL12765505 | 0.77 | THRB (0.32) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL12765764 | 0.77 | LMNA (0.35) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL12612218 | 0.76 | — | — | |
| SCHEMBL15149269 | 0.76 | — | — | |
| SCHEMBL12765492 | 0.74 | — | — | |
| SCHEMBL1897838 | 0.74 | LMNA (0.32) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 776 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12460126-B2 | Quantum dot, method of preparing the quantum dot, composition including the quantum dot, optical member including the quantum dot, and electronic apparatus including the quantum dot | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-11-04 | — | — | US | claimed |
| CN-119661364-A | Method for producing high-purity amantadine | 李果 | 2025-03-21 | — | — | CN | claimed |
| CN-119661366-A | Preparation method and application of amantadine carbonate | 李果 | 2025-03-21 | — | — | CN | claimed |
| CN-119661365-A | Novel method for producing amantadine hydrochloride | 李果 | 2025-03-21 | — | — | CN | claimed |
| CN-119303635-B | Cyclodextrin bionic organic iridium magnetic catalyst and preparation method and application thereof | 烟台大学 | 2025-03-14 | — | — | CN | claimed |
| CN-119331537-A | Method for preparing bamboo glued material by using principle of molecular recognition of host and guest and product | 西南林业大学 | 2025-01-21 | — | — | CN | claimed |
| CN-119303635-A | Cyclodextrin bionic organic iridium magnetic catalyst and preparation method and application thereof | 烟台大学 | 2025-01-14 | — | — | CN | claimed |
| CN-119143638-A | Preparation method of 2-adamantanoic acid-trifluoropropane sulfonic acid-derived high-purity electronic grade photoinduced acid generator | 苏州威迈芯材半导体有限公司 | 2024-12-17 | — | — | CN | claimed |
| US-20240383856-A1 | INHIBITORS OF TRANSGLUTAMINASES | ZEDIRA GMBH (DE) | 2024-11-21 | — | — | US | claimed |
| US-20240376055-A1 | INHIBITORS OF TRANSGLUTAMINASES | ZEDIRA GMBH (DE) | 2024-11-14 | — | — | US | claimed |
| WO-2002050129-A1 | PROCESS FOR POLYMERIZING CATIONICALLY POLYMERIZABLE MONOMERS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2002-06-27 | — | — | WO | claimed |
| EP-1159282-A1 | COMPOUNDS, PROCESSES AND INTERMEDIATES FOR SYNTHESIS OF MIXED BACKBONE OLIGOMERIC COMPOUNDS | ISIS PHARMACEUTICALS, INC. (US) | 2001-12-05 | — | — | EP | claimed |
| US-20010016652-A1 | Compounds, processes and intermediates for synthesis of mixed backbone oligomeric compounds | ISIS PHARMACEUTICALS, INC. | 2001-08-23 | — | — | US | claimed |
| US-6207819-B1 | SYNTHESIZING OLIGONUCLEOTIDE BY DEBLOCKING AND COUPLING NUCLEOTIDES TOGETHER, THEN TREATING WITH OXIDIZING SOLUTION TO CONVERT H-PHOSPHONATE LINKAGES TO PHOSPHODIESTER, PHOSPHOROTHIOATE, PHOSPHORAMIDATE OR BORANOPHOSPHATE | ISIS PHARMACEUTICALS, INC. | 2001-03-27 | — | — | US | claimed |
| WO-2000047593-A1 | COMPOUNDS, PROCESSES AND INTERMEDIATES FOR SYNTHESIS OF MIXED BACKBONE OLIGOMERIC COMPOUNDS | ISIS PHARMACEUTICALS, INC. (US) | 2000-08-17 | — | — | WO | claimed |
| EP-0618462-B1 | Gamma radiation detection | HARWELL DOSIMETERS LTD (GB) | 1998-07-29 | — | — | EP | claimed |
| US-5451792-A | System comprising carrier, haloadamantane producing halogen on radiation, leuco dye changing color by halogen; detectors in sterilizing medical equipment | HARTWELL DOSIMETERS LIMITED (GB) | 1995-09-19 | — | — | US | claimed |
| EP-0618462-A2 | Gamma radiation detection | Harwell Dosimeters Ltd (GB) | 1994-10-05 | — | — | EP | claimed |
| US-4894180-A | Liquid crystal optical element | FUJI PHOTO FILM CO., LTD. (JP) | 1990-01-16 | — | — | US | claimed |
| US-4711866-A | Adamantane polymerization catalyst | EXXON CHEMICAL PATENTS INC. (US) | 1987-12-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240383856-A1 | INHIBITORS OF TRANSGLUTAMINASES | TGM2, TGM3, TGM1 | GRIN2D 2878/4885GRIN3B 2929/4885GRIN1 2076/4885 |
| US-20010016652-A1 | Compounds, processes and intermediates for synthesis of mixed backbone oligomeric compounds | PPIP5K2, NUDT1, ITPA | GRIN2D 4608/4885GRIN3B 3671/4885GRIN1 3969/4885 |
| US-20240376055-A1 | INHIBITORS OF TRANSGLUTAMINASES | TGM2, TGM3, TGM1 | GRIN2D 2878/4885GRIN3B 2929/4885GRIN1 2076/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.